Sanuwave Health Net Income 2010-2024 | SNWVD
Sanuwave Health net income from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Sanuwave Health Annual Net Income
(Millions of US $) |
| 2023 |
$-26 |
| 2022 |
$-10 |
| 2021 |
$-27 |
| 2020 |
$-31 |
| 2019 |
$-10 |
| 2018 |
$-12 |
| 2017 |
$-6 |
| 2016 |
$-6 |
| 2015 |
$-5 |
| 2014 |
$-6 |
| 2013 |
$-11 |
| 2012 |
$-6 |
| 2011 |
$-10 |
| 2010 |
$-15 |
| 2009 |
$-6 |
Sanuwave Health Quarterly Net Income
(Millions of US $) |
| 2024-06-30 |
$7 |
| 2024-03-31 |
$-5 |
| 2023-12-31 |
$18 |
| 2023-09-30 |
$-24 |
| 2023-06-30 |
$-7 |
| 2023-03-31 |
$-13 |
| 2022-12-31 |
$-6 |
| 2022-09-30 |
$-1 |
| 2022-06-30 |
$2 |
| 2022-03-31 |
$-5 |
| 2021-12-31 |
$-9 |
| 2021-09-30 |
$-4 |
| 2021-06-30 |
$-9 |
| 2021-03-31 |
$-5 |
| 2020-12-31 |
$-12 |
| 2020-09-30 |
$-13 |
| 2020-06-30 |
$-4 |
| 2020-03-31 |
$-3 |
| 2019-12-31 |
$-3 |
| 2019-09-30 |
$-3 |
| 2019-06-30 |
$-3 |
| 2019-03-31 |
$-2 |
| 2018-12-31 |
$-2 |
| 2018-09-30 |
$-1 |
| 2018-06-30 |
$-3 |
| 2018-03-31 |
$-6 |
| 2017-12-31 |
$-3 |
| 2017-09-30 |
$-1 |
| 2017-06-30 |
$-1 |
| 2017-03-31 |
$-0 |
| 2016-12-31 |
$-2 |
| 2016-09-30 |
$-1 |
| 2016-06-30 |
$-1 |
| 2016-03-31 |
$-2 |
| 2015-12-31 |
$-1 |
| 2015-09-30 |
$-1 |
| 2015-06-30 |
$-2 |
| 2015-03-31 |
$-1 |
| 2014-12-31 |
$-0 |
| 2014-09-30 |
$-1 |
| 2014-06-30 |
$-2 |
| 2014-03-31 |
$-3 |
| 2013-12-31 |
$-1 |
| 2013-09-30 |
$-4 |
| 2013-06-30 |
$-1 |
| 2013-03-31 |
$-5 |
| 2012-12-31 |
$-2 |
| 2012-09-30 |
$-1 |
| 2012-06-30 |
$-1 |
| 2012-03-31 |
$-2 |
| 2011-12-31 |
$-2 |
| 2011-09-30 |
$-2 |
| 2011-06-30 |
$-4 |
| 2011-03-31 |
$-2 |
| 2010-12-31 |
$-7 |
| 2010-09-30 |
$-3 |
| 2010-06-30 |
$-3 |
| 2010-03-31 |
$-3 |
| 2009-12-31 |
$-3 |
| 2009-09-30 |
$-3 |
| 2009-06-30 |
$1 |
| 2009-03-31 |
$-2 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$0.056B |
$0.020B |
|
SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA.
|
